Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
Metrics | Range | Conclusion |
---|---|---|
Selected LTM Ps Multiple | 0.7x - 0.8x | 0.8x |
Selected Fwd Ps Multiple | 0.9x - 1.0x | 1.0x |
Fair Value | A$1.80 - A$1.99 | A$1.89 |
Upside | 28.5% - 42.0% | 35.2% |
Benchmarks | Ticker | Full Ticker |
---|---|---|
Sonic Healthcare Limited | - | ASX:SHL |
Australian Clinical Labs Limited | - | ASX:ACL |
Ramsay Health Care Limited | - | ASX:RHC |
Freedom Care Group Holdings Limited | - | ASX:FCG |
Rhythm Biosciences Limited | - | ASX:RHY |
Healius Limited | - | ASX:HLS |
Select Price / LTM Sales Ratio | ||||||||
Benchmark Companies | ||||||||
SHL | ACL | RHC | FCG | RHY | HLS | |||
ASX:SHL | ASX:ACL | ASX:RHC | ASX:FCG | ASX:RHY | ASX:HLS | |||
Historical Sales Growth | ||||||||
5Y CAGR | 7.9% | 9.2% | 7.6% | NM- | 10.5% | 2.2% | ||
3Y CAGR | 0.8% | 2.5% | 9.0% | NM- | 15.1% | -3.0% | ||
Latest Twelve Months | 11.2% | 8.0% | 7.4% | 37.8% | 53.3% | 22.1% | ||
Historical Net Income Profit Margin | ||||||||
5 Year Average Margin | 10.9% | 9.5% | 3.3% | 7.6% | -570.1% | -10.0% | ||
Prior Fiscal Year | 8.4% | 5.2% | 1.8% | 11.2% | -265.4% | -22.3% | ||
Latest Fiscal Year | 5.7% | 3.4% | 1.5% | 2.7% | -405.7% | -36.4% | ||
Latest Twelve Months | 5.8% | 4.2% | 0.0% | 2.7% | -68.7% | -1.8% | ||
Current Trading Multiples | ||||||||
EV / LTM EBITDA | 12.8x | 10.9x | 12.6x | 1.5x | -7.7x | 24.0x | ||
Price / LTM Sales | 1.3x | 0.8x | 0.4x | 0.1x | 6.3x | 0.6x | ||
LTM P/E Ratio | 21.9x | 18.7x | 933.9x | 4.9x | -9.1x | -31.1x | ||
Low | Mid | High | ||||||
Benchmark LTM P/S Ratio | 0.1x | 0.8x | 6.3x | |||||
Historical LTM P/S Ratio | 1.5x | 1.5x | 1.5x | |||||
Selected Price / Sales Multiple | 0.7x | 0.8x | 0.8x | |||||
(x) LTM Sales | 1,788 | 1,788 | 1,788 | |||||
(=) Equity Value | 1,314 | 1,383 | 1,452 | |||||
(/) Shares Outstanding | 726.1 | 726.1 | 726.1 | |||||
Implied Value Range | 1.81 | 1.90 | 2.00 | |||||
FX Rate: AUD/AUD | 1.0 | 1.0 | 1.0 | Market Price | ||||
Implied Value Range (Trading Cur) | 1.81 | 1.90 | 2.00 | 1.40 | ||||
Upside / (Downside) | 29.2% | 36.0% | 42.8% |
Equity Value | |||||||
Benchmark Companies | |||||||
(in millions) | SHL | ACL | RHC | FCG | RHY | HLS | |
Value of Common Equity | 11,924 | 575 | 7,471 | 4 | 20 | 1,017 | |
(/) Shares Outstanding | 480.2 | 197.5 | 229.3 | 108.3 | 283.6 | 726.1 | |
Implied Stock Price | 24.83 | 2.91 | 32.59 | 0.04 | 0.07 | 1.40 | |
FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
Implied Stock Price (Trading Cur) | 24.83 | 2.91 | 32.59 | 0.04 | 0.07 | 1.40 | |
Trading Currency | AUD | AUD | AUD | AUD | AUD | AUD | |
FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |